Frequencies That Heal

“The winning modality will be the one that scales. That is a platform question, and it is the right one to ask.”

— Ken Mayer, Co-founder & Chief Executive Officer

Signal-based therapy is older than most people assume. Transcutaneous electrical nerve stimulation arrived in the 1960s, offering relief by delivering pulses through the skin. Vagus nerve stimulation followed in the 1990s, engaging a major nerve to influence the nervous and immune systems. Both proved that electricity could be medicine. Both also came with real limits — TENS tends to be shallow in its reach, and VNS, in its established forms, is invasive.

As an engineer comparing tools, I care about those limits because they determine how far a technology can go.

Why PEMF is interesting as a platform

Pulsed electromagnetic fields occupy a different point in the design space. PEMF is non-invasive and can penetrate deeply, interacting with ion channels, calcium flux, and intracellular signaling. It has been applied across a notably wide range — post-operative pain and edema, fracture healing, biofilm disruption, and various regeneration models. That breadth is the tell. A modality that touches many tissues and many problems is a candidate for a platform, not just a point solution.

A TENS therapy unit with electrode leads. Set side by side, the contrast is clear. TENS and VNS are valuable but constrained. PEMF is programmable: change the waveform, the frequency, and the dose, and you change what the therapy does. Programmability is exactly what lets one underlying engine serve many applications — the property that turns a device into a platform.

“Frequency is a language the body already understands. Our job is to become fluent enough to use it responsibly.”

— Ken Mayer, Co-founder & Chief Executive Officer

A bioelectric operating system

This is why I describe the Electrome platform as a bioelectric operating system. It pairs biosensors that read the body's state, AI-driven waveform optimization that computes the right signal, and real-time feedback that closes the loop. The ambition is one programmable PEMF engine supporting many therapeutic applications through sensing, computation, and adaptation.

I will not claim the question of “which modality wins” is settled — it is an open scientific and clinical contest. But if the prize goes to the approach that can scale across many conditions while adapting to tissues and healing states, programmable, frequency-based therapy is a strong contender, and worth building for.

A visualization of sound-wave frequencies.